Alisertib Synergistically Strengthens the Anti-Leukemia Activity of Venetoclax in TCF3-HLF B-ALL

Presenter Information

Colin WakefieldFollow

Presentation Type

Clinical Research

Recommended Citation

Wakefield, Colin, "Alisertib Synergistically Strengthens the Anti-Leukemia Activity of Venetoclax in TCF3-HLF B-ALL" (2022). St. Chris Research Day. 5.
https://scholarcommons.towerhealth.org/schc_researchday/2022/clinical_research/5